Literature DB >> 1548672

Importance of routine measurement of HDL with total cholesterol in diabetic patients.

M D Feher1, J Stevens, A F Lant, P D Mayne.   

Abstract

The prevalence of hypercholesterolaemia and the frequency of a reduced HDL-cholesterol (at different cholesterol concentrations) were evaluated in a group of 400 diabetic patients attending a single diabetic clinic. Despite regularly supervised diabetes, including dietary advice, over one quarter of the patients had a serum total cholesterol concentration greater than 6.5 mmol/l, while over a quarter of the non-insulin treated and one eighth of the insulin treated diabetic subjects had an HDL-cholesterol less than 0.9 mmol/l, with a greater prevalence in the males compared with the females. More than 60% of all the diabetic patients who had a reduced HDL-cholesterol less than 0.9 mmol/l also had a total cholesterol concentration less than 6.5 mmol/l. When the total/HDL-cholesterol ratio was calculated more non-insulin treated subjects had a value greater than 4.5 as compared with insulin treated diabetic patients. When comparisons were made between an age matched group of diabetic patients (n = 185) and a group of non-diabetic subjects attending for a health screen (n = 155), the frequencies of serum cholesterol concentrations greater than 5.2, 6.5, and 7.8 mmol/l were similar for both groups. Significantly greater numbers of diabetic patients had a reduced HDL-cholesterol less than 0.9 mmol/l (at any level of serum cholesterol) and a total/HDL cholesterol ratio greater than 4.5. This study has shown that the measurement of serum total cholesterol concentration alone will not characterize many subjects who are at risk of macrovascular complications due to a reduced HDL-cholesterol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548672      PMCID: PMC1293452          DOI: 10.1177/014107689208500104

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  19 in total

1.  Beta-blockers, lipoproteins and non-insulin dependent diabetes.

Authors:  M D Feher; S G Rains; W Richmond; D Torrens; G Wilson; J Wadsworth; P S Sever; R S Elkeles
Journal:  Postgrad Med J       Date:  1988-12       Impact factor: 2.401

2.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

3.  Lipid screening: is it enough to measure total cholesterol concentration?

Authors:  H A Neil; D Mant; L Jones; B Morgan; J I Mann
Journal:  BMJ       Date:  1990-09-22

4.  Persistence of hypertriglyceridemic effect of low-fat high-carbohydrate diets in NIDDM patients.

Authors:  A M Coulston; C B Hollenbeck; A L Swislocki; G M Reaven
Journal:  Diabetes Care       Date:  1989-02       Impact factor: 19.112

5.  Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

Authors:  A Rosengren; L Welin; A Tsipogianni; L Wilhelmsen
Journal:  BMJ       Date:  1989-11-04

6.  Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Ann Intern Med       Date:  1977-10       Impact factor: 25.391

7.  Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

8.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

Review 9.  Polyunsaturated and saturated fat, cholesterol, and fatty acid supplementation.

Authors:  A Kissebah; G Schectman
Journal:  Diabetes Care       Date:  1988-02       Impact factor: 19.112

10.  Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

View more
  1 in total

Review 1.  Microvascular investigations in diabetes mellitus.

Authors:  S J Chittenden; S K Shami
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.